These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 18165351

  • 1. Comment on: Knop et al. (2007) Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56:1951-1959.
    Choukem SP, Gautier JF.
    Diabetes; 2008 Jan; 57(1):e1; author reply e2-3. PubMed ID: 18165351
    [No Abstract] [Full Text] [Related]

  • 2. Comment on: Villareal et al. (2009) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes;59:479-485.
    Knop FK.
    Diabetes; 2010 Jun; 59(6):e4; author reply e5-6. PubMed ID: 20508220
    [No Abstract] [Full Text] [Related]

  • 3. Beyond glycemic control: the effects of incretin hormones in type 2 diabetes.
    Martin CL.
    Diabetes Educ; 2008 Jun; 34 Suppl 3():66S-72S. PubMed ID: 18525067
    [Abstract] [Full Text] [Related]

  • 4. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes].
    Fabreegas B.
    Soins; 2008 Jun; (726):34-7. PubMed ID: 18697336
    [No Abstract] [Full Text] [Related]

  • 5. Targeting the incretin system in type 2 diabetes mellitus.
    Potenza M, Rayfield EJ.
    Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
    [Abstract] [Full Text] [Related]

  • 6. [Antidiabetics and the incretin system].
    Høibraaten E, Folkersen J.
    Tidsskr Nor Laegeforen; 2008 Sep 11; 128(17):1985. PubMed ID: 18787580
    [No Abstract] [Full Text] [Related]

  • 7. Incretin based therapies for type 2 diabetes mellitus.
    Ghosh S, Collier A, Elhadd T, Malik I.
    J Indian Med Assoc; 2008 Jun 11; 106(6):373-4, 383, 388. PubMed ID: 18839649
    [Abstract] [Full Text] [Related]

  • 8. Incretins: the novel therapy of type 2 diabetes.
    Thongtang N, Sriwijitkamol A.
    J Med Assoc Thai; 2008 Jun 11; 91(6):943-54. PubMed ID: 18697398
    [Abstract] [Full Text] [Related]

  • 9. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Ranganath LR.
    J Clin Pathol; 2008 Apr 11; 61(4):401-9. PubMed ID: 18375745
    [Abstract] [Full Text] [Related]

  • 10. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M, Magnan C, Kargar C.
    Diabetes Metab; 2009 Apr 11; 35(2):77-84. PubMed ID: 19251449
    [Abstract] [Full Text] [Related]

  • 11. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK.
    J Am Pharm Assoc (2003); 2009 Apr 11; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [Abstract] [Full Text] [Related]

  • 12. [Incretin strategy in the treatment of type 2 diabetes mellitus--DPPIV--editorial].
    Rybka J.
    Vnitr Lek; 2007 Sep 11; 53(9):934-5. PubMed ID: 18019660
    [No Abstract] [Full Text] [Related]

  • 13. Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes.
    Pratley RE.
    J Am Acad Nurse Pract; 2008 Nov 11; 20 Suppl 1():7-11. PubMed ID: 19402254
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK, Holst JJ, Vilsbøll T.
    IDrugs; 2008 Jul 11; 11(7):497-501. PubMed ID: 18600596
    [Abstract] [Full Text] [Related]

  • 16. Mining incretin hormone pathways for novel therapies.
    Wideman RD, Kieffer TJ.
    Trends Endocrinol Metab; 2009 Aug 11; 20(6):280-6. PubMed ID: 19595611
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S.
    Diabetes Metab; 2008 Feb 11; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G.
    Nutr Metab Cardiovasc Dis; 2008 Oct 11; 18(8):574-9. PubMed ID: 18790374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.